Authors
No takes yet. Share an insight, caveat, or question.
Preclinical study demonstrates HIC1 deletion accelerates breast cancer progression in mouse models, highlighting therapeutic microenvironment targets.
Wang et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: